Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-08-027099
Filing Date
2008-05-08
Accepted
2008-05-08 17:55:25
Documents
1
Period of Report
2008-05-01

Document Format Files

Seq Description Document Type Size
1 v113366_ex.html 3  
1 v113366_ex.xml 3 1545
  Complete submission text file 0001144204-08-027099.txt   3495
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 HAMEYADSIM ST KIRYAT ONO L3 55521
Business Address 972 54 223 4191
ORLEV CHAIME (Reporting) CIK: 0001345636 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50298 | Film No.: 08815436